Varenicline, nicotine patch combo helps heavy drinkers quit smoking, study finds
The combination of nicotine replacement therapy and the prescription drug varenicline is more effective for smoking cessation in people who are heavy drinkers than either method alone, a JAMA Network Open study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 4, 2022 Category: Consumer Health News Source Type: news

Tobacco: preventing uptake, promoting quitting and treating dependence guidance [NG209], NICE ( published 30th November 2021)
This guideline covers support to stop smoking for everyone aged 12 and over, and help to reduce people ' s harm from smoking if they are not ready to stop in one go. It also covers ways to prevent children, young people and young adults aged 24 and under from taking up smoking. The guideline brings together and updates all NICE ' s previous guidelines on using tobacco, including smokeless tobacco. It covers nicotine replacement therapy and e-cigarettes to help people stop smoking or reduce their harm from smoking. It does not cover using tobacco products such as ' heat not burn ' tobacco. In November 2021, varenicline was...
Source: Current Awareness Service for Health (CASH) - December 1, 2021 Category: Consumer Health News Source Type: news

Tyrvaya (Varenicline Solution Nasal Spray) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 2, 2021 Category: Drugs & Pharmacology Source Type: news

Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
TYRVAYA is the first and only nasal spray approved for the treatment of the signs and symptoms of dry eye disease TYRVAYA is designed to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment ... Biopharmaceuticals, Ophthalmology, FDA Oyster Point Pharma, TYRVAYA, varenicline, dry eye disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2021 Category: Pharmaceuticals Source Type: news

Class 2 Medicines Recall: Pfizer Ltd, Champix (all strengths) film-coated tablets
Pfizer Ltd are recalling all in-date batches of Champix (varenicline) as a precautionary measure due to presence of levels of N-nitroso-varenicline above the acceptable level of intake. This recall al (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 14, 2021 Category: Drugs & Pharmacology Source Type: news

Combined treatments are the most effective to stop smoking, study finds
Combination therapies, particularly varenicline and nicotine replacement therapy (NRT) combined, are the most effective tobacco cessation pharmacotherapies, the largest review to examine the effectiveness and safety of electronic cigarettes (e-cigarettes) and medicines that people use to quit tobacco has found. (Source: University of Bristol news)
Source: University of Bristol news - October 12, 2021 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news

Pfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential Carcinogen
Title: Pfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential CarcinogenCategory: Health NewsCreated: 9/17/2021 12:00:00 AMLast Editorial Review: 9/20/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 20, 2021 Category: Respiratory Medicine Source Type: news

Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX(R) (varenicline) Tablets Due to N- Nitroso Varenicline Content
NEW YORK, NY, Sept 19, 2021 -- Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable D... Biopharmaceuticals, FDA, Product Recall Pfizer, CHANTIX, varenicline (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2021 Category: Pharmaceuticals Source Type: news

Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen
0.5 - mg and 1 - mg tablets may contain levels of N - nitroso - varenicline at or above levels approved by the FDA (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 18, 2021 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Institutional, Source Type: news

Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer
Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer. (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2021 Category: Consumer Health News Source Type: news

Pfizer recalls all lots of Chantix for high levels of nitrosamine, which can increase cancer risk
Pfizer is voluntarily recalling lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the... (Source: Reuters: Health)
Source: Reuters: Health - September 17, 2021 Category: Consumer Health News Source Type: news

Pfizer Expands Recall of Antismoking Drug to Include All Lots Pfizer Expands Recall of Antismoking Drug to Include All Lots
Ongoing concerns over a nitrosamine impurity in Chantix prompt Pfizer to recall all batches of the product in the United States as a precautionary measure.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX ® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit. As alternative suppliers have been approved in the United States, Pfizer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 17, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news